Immature platelet fraction as a biomarker for disease severity in pediatric respiratory coronavirus disease 2019

Nicholas C.J. Lee, Yusuf Kemal Demir, Bilal Ashraf, Ibrahim Ibrahim, Taha Bat, Kathryn E. Dickerson

Research output: Contribution to journalArticlepeer-review

Abstract

In this retrospective single-institution cohort study of 113 hospitalized pediatric patients with respiratory coronavirus disease 2019, those admitted to the intensive care unit or requiring mechanical ventilation had significantly higher immature platelet fractions than those who did not require intensive care unit–level care or ventilation. Immature platelet fraction may be an accessible biomarker for disease severity in pediatric respiratory coronavirus disease 2019.

Original languageEnglish (US)
JournalJournal of Pediatrics
DOIs
StateAccepted/In press - 2022

Keywords

  • biomarker
  • COVID-19
  • immature platelet
  • pediatric
  • SARS-CoV-2

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Immature platelet fraction as a biomarker for disease severity in pediatric respiratory coronavirus disease 2019'. Together they form a unique fingerprint.

Cite this